• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAMTS13催化作用的机制研究。

Mechanistic studies on ADAMTS13 catalysis.

作者信息

Di Stasio Enrico, Lancellotti Stefano, Peyvandi Flora, Palla Roberta, Mannucci Pier Mannuccio, De Cristofaro Raimondo

机构信息

Institute of Biochemistry and Clinical Biochemistry, Catholic University School of Medicine, Rome, Italy.

出版信息

Biophys J. 2008 Sep;95(5):2450-61. doi: 10.1529/biophysj.108.131532. Epub 2008 May 23.

DOI:10.1529/biophysj.108.131532
PMID:18502798
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2517044/
Abstract

The zinc-protease a disintegrin-like and metalloprotease with thrombospondin type I repeats (ADAMTS13) cleaves the Tyr(1605)-Met(1606) peptide bond of von Willebrand factor (VWF), avoiding the accumulation of ultra large VWF multimers. Hydrolysis by ADAMTS13 of a VWF analog (Asp(1596)-Arg(1668) peptide, fluorescence energy transfer substrate [FRETS]-VWF73) was investigated by a fluorescence quenching method (FRETS method) from 15 degrees C to 45 degrees C and pH values from 4.5 to 10.5. The catalysis was influenced by two ionizable groups, whose pK(a) values were equal to 6.41 +/- 0.08 (ionization enthalpy = 32.6 +/- 1.7 kJ/mol) and 4 +/- 0.1 (ionization enthalpy = 3.8 +/- 0.4 kJ/mol), whereas these values were equal to 6 +/- 0.1 and 4.1 +/- 0.1, respectively, in Co(2+)-substituted ADAMTS13. The catalytic process of FRETS-VWF73 hydrolysis showed negative activation entropy (-144 kJ/mol), suggesting that the transition state becomes more ordered than the ground state of the reactants. The k(cat)/K(m) values were not linearly correlated with temperature, as expression of change of the kinetic "stickiness" of the substrate. The Met(1606)-Arg(1668) peptide product acted as hyperbolic mixed-type inhibitor of FRETS-VWF73 hydrolysis. Asp(1653), Glu(1655), Glu(1660), Asp(1663), together with the hydrophilic side chain of Thr(1656) were shown to form a "hot spot" in the VWF A2 sequence, which drives the molecular recognition and allosteric regulation of binding to ADAMTS13. The interaction of the Met(1606)-Arg(1668) region of VWF with ADAMTS13 involves basic residues of the protease and is thus progressively inhibited at pH values >8.50. A molecular model of the FRETS-VWF73 showed that the substrate can fit into the active site only if ADAMTS13 assumes a C-like shape and, interacting with the acidic 1653-1668 region of VWF, properly orients the Tyr(1605)-Met(1606) peptide bond for the cleavage by the zinc-aquo complex in the active site.

摘要

锌蛋白酶——具有I型血小板反应蛋白基序的解聚素样金属蛋白酶(ADAMTS13)可裂解血管性血友病因子(VWF)的Tyr(1605)-Met(1606)肽键,避免超大VWF多聚体的积累。通过荧光猝灭法(荧光共振能量转移法)在15℃至45℃以及pH值为4.5至10.5的条件下研究了ADAMTS13对VWF类似物(Asp(1596)-Arg(1668)肽,荧光共振能量转移底物[FRETS]-VWF73)的水解作用。催化作用受两个可电离基团影响,其pK(a)值分别为6.41±0.08(电离焓=32.6±1.7 kJ/mol)和4±0.1(电离焓=3.8±0.4 kJ/mol),而在Co(2+)取代的ADAMTS13中,这些值分别为6±0.1和4.1±0.1。FRETS-VWF73水解的催化过程显示出负的活化熵(-144 kJ/mol),表明过渡态比反应物的基态更加有序。k(cat)/K(m)值与温度并非线性相关,这体现了底物动力学“粘性”的变化。Met(1606)-Arg(1668)肽产物作为FRETS-VWF73水解的双曲线混合型抑制剂。Asp(1653)、Glu(1655)、Glu(1660)、Asp(1663)以及Thr(1656)的亲水性侧链在VWF A2序列中形成一个“热点”,驱动与ADAMTS13结合的分子识别和变构调节。VWF的Met(1606)-Arg(1668)区域与ADAMTS13的相互作用涉及蛋白酶的碱性残基,因此在pH值>8.50时逐渐受到抑制。FRETS-VWF73的分子模型表明,只有当ADAMTS13呈现C样形状并与VWF的酸性1653-1668区域相互作用时,底物才能进入活性位点,并使Tyr(1605)-Met(1606)肽键正确定向,以便活性位点中的锌水络合物进行裂解。

相似文献

1
Mechanistic studies on ADAMTS13 catalysis.ADAMTS13催化作用的机制研究。
Biophys J. 2008 Sep;95(5):2450-61. doi: 10.1529/biophysj.108.131532. Epub 2008 May 23.
2
Zinc and calcium ions cooperatively modulate ADAMTS13 activity.锌离子和钙离子协同调节ADAMTS13活性。
J Biol Chem. 2006 Jan 13;281(2):850-7. doi: 10.1074/jbc.M504540200. Epub 2005 Nov 11.
3
Leukocyte proteases cleave von Willebrand factor at or near the ADAMTS13 cleavage site.白细胞蛋白酶在ADAMTS13裂解位点或其附近裂解血管性血友病因子。
Blood. 2009 Aug 20;114(8):1666-74. doi: 10.1182/blood-2009-01-195461. Epub 2009 Jun 18.
4
FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients.FRETS-VWF73 检测而非 CBA assay 可反映获得性血栓性血小板减少性紫癜患者 ADAMTS13 的蛋白水解活性。
Thromb Haemost. 2014 Aug;112(2):297-303. doi: 10.1160/TH13-08-0688. Epub 2014 Apr 17.
5
The proximal carboxyl-terminal domains of ADAMTS13 determine substrate specificity and are all required for cleavage of von Willebrand factor.ADAMTS13的近端羧基末端结构域决定底物特异性,并且都是切割血管性血友病因子所必需的。
J Biol Chem. 2005 Aug 19;280(33):29428-34. doi: 10.1074/jbc.M505513200. Epub 2005 Jun 23.
6
Mechanism of von Willebrand factor scissile bond cleavage by a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13).血管性血友病因子剪切键断裂的机制由解整合素和金属蛋白酶与血小板反应蛋白 1 型基序,成员 13(ADAMTS13)。
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11602-7. doi: 10.1073/pnas.1018559108. Epub 2011 Jun 24.
7
Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement.使用VWF-73肽的显色商业检测法评估ADAMTS13活性的测定。
Thromb Res. 2014 Nov;134(5):1074-80. doi: 10.1016/j.thromres.2014.09.006. Epub 2014 Sep 16.
8
Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.ADAMTS13 间隔区的氨基酸残基 Arg(659)、Arg(660)和 Tyr(661)对于 von Willebrand 因子的裂解至关重要。
Blood. 2010 Mar 18;115(11):2300-10. doi: 10.1182/blood-2009-07-235101. Epub 2010 Jan 14.
9
FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay.FRETS-VWF73,一种用于ADAMTS13检测的首个荧光底物。
Br J Haematol. 2005 Apr;129(1):93-100. doi: 10.1111/j.1365-2141.2005.05420.x.
10
The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity.ADAMTS13 的 TSR1 中的 WXXW 基序对其分泌和蛋白水解活性很重要。
Thromb Res. 2013 Jun;131(6):529-34. doi: 10.1016/j.thromres.2013.04.024. Epub 2013 May 14.

引用本文的文献

1
Mechanisms of inhibition of human monoclonal antibodies in immune thrombotic thrombocytopenic purpura.人类单克隆抗体在免疫性血栓性血小板减少性紫癜中的抑制机制。
Blood. 2023 Jun 15;141(24):2993-3005. doi: 10.1182/blood.2022019252.
2
Mechanisms of ADAMTS13 regulation.ADAMTS13 的调控机制。
J Thromb Haemost. 2022 Dec;20(12):2722-2732. doi: 10.1111/jth.15873. Epub 2022 Sep 22.
3
ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura.ADAMTS13 构象及其在免疫性血栓性血小板减少性紫癜中的抑制机制。
J Thromb Haemost. 2022 Oct;20(10):2197-2203. doi: 10.1111/jth.15822. Epub 2022 Aug 3.
4
The activity of the intrinsically water-soluble enzyme ADAMTS13 correlates with the membrane state when bound to a phospholipid bilayer.当结合到磷脂双层时,内在水溶性酶 ADAMTS13 的活性与膜状态相关。
Sci Rep. 2021 Dec 28;11(1):24476. doi: 10.1038/s41598-021-04083-0.
5
Peptide-Based Inhibitors of ADAM and ADAMTS Metalloproteinases.基于肽的ADAM和ADAMTS金属蛋白酶抑制剂
Front Mol Biosci. 2021 Jul 21;8:703715. doi: 10.3389/fmolb.2021.703715. eCollection 2021.
6
A human monoclonal antibody against the distal carboxyl terminus of ADAMTS-13 modulates its susceptibility to an inhibitor in thrombotic thrombocytopenic purpura.一种针对 ADAMTS-13 远端羧基末端的人源单克隆抗体调节其对血栓性血小板减少性紫癜抑制剂的敏感性。
J Thromb Haemost. 2021 Aug;19(8):1888-1895. doi: 10.1111/jth.15332. Epub 2021 May 11.
7
Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies.血栓性微血管病鉴别诊断的诊断性检测
Turk J Haematol. 2019 Nov 18;36(4):222-229. doi: 10.4274/tjh.galenos.2019.2019.0165. Epub 2019 Jul 24.
8
AFM Imaging Reveals Multiple Conformational States of ADAMTS13.原子力显微镜成像揭示了ADAMTS13的多种构象状态。
J Biol Eng. 2019 Jan 22;13:9. doi: 10.1186/s13036-018-0102-y. eCollection 2019.
9
Prediction of spacer-α6 complex: a novel insight into binding of ADAMTS13 with A2 domain of von Willebrand factor under forces.预测间隔-α6 复合物:在力的作用下,ADAMTS13 与 von Willebrand 因子 A2 结构域结合的新见解。
Sci Rep. 2018 Apr 10;8(1):5791. doi: 10.1038/s41598-018-24212-6.
10
Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study.肝硬化患者门静脉血栓形成与ADAMTS-13水平降低密切相关:一项初步研究。
Intern Emerg Med. 2016 Oct;11(7):959-67. doi: 10.1007/s11739-016-1467-x. Epub 2016 May 24.

本文引用的文献

1
Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress.在流体剪切应力作用下,血小板-血管性血友病因子复合物是ADAMTS13的首选底物。
Blood. 2008 Jan 15;111(2):651-7. doi: 10.1182/blood-2007-05-093021. Epub 2007 Sep 27.
2
Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.人类ADAMTS-1的晶体结构揭示了一个保守的催化结构域和一个与富含半胱氨酸结构域折叠同源的解整合素样结构域。
J Mol Biol. 2007 Nov 2;373(4):891-902. doi: 10.1016/j.jmb.2007.07.047. Epub 2007 Aug 2.
3
Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease.外位点相互作用有助于抗血栓性ADAMTS13金属蛋白酶对血管性血友病因子的张力诱导切割。
Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19099-104. doi: 10.1073/pnas.0607264104. Epub 2006 Dec 4.
4
Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor.血管性血友病因子A2结构域中ADAMTS-13核心结合位点的鉴定
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18470-4. doi: 10.1073/pnas.0609190103. Epub 2006 Nov 22.
5
Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13.2B型和2M型血管性血友病疾病突变对血管性血友病因子对ADAMTS-13敏感性的影响。
J Thromb Haemost. 2007 Feb;5(2):321-8. doi: 10.1111/j.1538-7836.2007.02296.x. Epub 2006 Nov 1.
6
Molecular mapping of the chloride-binding site in von Willebrand factor (VWF): energetics and conformational effects on the VWF/ADAMTS-13 interaction.血管性血友病因子(VWF)中氯离子结合位点的分子图谱:对VWF/ADAMTS-13相互作用的能量学和构象影响
J Biol Chem. 2006 Oct 13;281(41):30400-11. doi: 10.1074/jbc.M603321200. Epub 2006 Aug 9.
7
Impact of mutations in the von Willebrand factor A2 domain on ADAMTS13-dependent proteolysis.血管性血友病因子A2结构域突变对ADAMTS13依赖性蛋白水解的影响。
Blood. 2006 Mar 15;107(6):2339-45. doi: 10.1182/blood-2005-04-1758. Epub 2005 Dec 1.
8
ADAMTS13 substrate recognition of von Willebrand factor A2 domain.ADAMTS13对血管性血友病因子A2结构域的底物识别。
J Biol Chem. 2006 Jan 20;281(3):1555-63. doi: 10.1074/jbc.M508316200. Epub 2005 Oct 12.
9
Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions.在流动条件下,ADAMTS - 13对超大血管性血友病因子的裂解作用。
J Thromb Haemost. 2005 Aug;3(8):1710-6. doi: 10.1111/j.1538-7836.2005.01360.x.
10
Theoretical structural explanation for Group I and Group II, type 2A von Willebrand disease mutations.
J Thromb Haemost. 2005 Apr;3(4):796-7. doi: 10.1111/j.1538-7836.2005.01219.x.